| { | |
| "industryId": "pharma", | |
| "name": "제약·바이오", | |
| "totalRevenue": 550908, | |
| "nodeCount": 271, | |
| "stages": [ | |
| { | |
| "key": "research", | |
| "name": "연구·신약개발", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "nodes": [ | |
| { | |
| "stockCode": "207940", | |
| "corpName": "삼성바이오로직스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 45570, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": 5.9, | |
| "opMargin": 46.2, | |
| "debtRatio": 51.4, | |
| "revCagr": 13.2, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "068270", | |
| "corpName": "셀트리온", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 41625, | |
| "confidence": 0.76, | |
| "source": "docs", | |
| "roe": 2.0, | |
| "opMargin": 28.1, | |
| "debtRatio": 30.0, | |
| "revCagr": 29.8, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "005250", | |
| "corpName": "녹십자홀딩스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 24515, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": 170.9, | |
| "opMargin": 0.6, | |
| "debtRatio": 139.5, | |
| "revCagr": -0.4, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "085660", | |
| "corpName": "차바이오텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 12683, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -0.5, | |
| "opMargin": -9.3, | |
| "debtRatio": 173.8, | |
| "revCagr": 11.2, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "003850", | |
| "corpName": "보령", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 10174, | |
| "confidence": 0.7, | |
| "source": "docs", | |
| "roe": 4.7, | |
| "opMargin": 7.9, | |
| "debtRatio": 60.5, | |
| "revCagr": -33.3, | |
| "profGrade": "보통", | |
| "debtGrade": "관찰", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "086450", | |
| "corpName": "동국제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 9269, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 3.4, | |
| "opMargin": 10.9, | |
| "debtRatio": 39.8, | |
| "revCagr": 11.6, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "084110", | |
| "corpName": "휴온스글로벌", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 8475, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 2.8, | |
| "opMargin": 4.7, | |
| "debtRatio": 42.5, | |
| "revCagr": 1.1, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "170900", | |
| "corpName": "동아에스티", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 8088, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 1.2, | |
| "opMargin": 3.8, | |
| "debtRatio": 98.8, | |
| "revCagr": -32.6, | |
| "profGrade": "저수익", | |
| "debtGrade": "고위험", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "137310", | |
| "corpName": "에스디바이오센서", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 7106, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": 0.9, | |
| "opMargin": -6.0, | |
| "debtRatio": 24.1, | |
| "revCagr": 2.0, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "326030", | |
| "corpName": "에스케이바이오팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 7067, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 11.0, | |
| "opMargin": 39.4, | |
| "debtRatio": 41.7, | |
| "revCagr": -13.7, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "302440", | |
| "corpName": "SK바이오사이언스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 6514, | |
| "confidence": 0.933, | |
| "source": "docs", | |
| "roe": -1.8, | |
| "opMargin": -26.4, | |
| "debtRatio": 47.8, | |
| "revCagr": -23.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "271980", | |
| "corpName": "제일약품", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 5672, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 1.3, | |
| "opMargin": 0.3, | |
| "debtRatio": 100.1, | |
| "revCagr": -12.0, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "249420", | |
| "corpName": "일동제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 5669, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 3.1, | |
| "opMargin": 6.5, | |
| "debtRatio": 134.3, | |
| "revCagr": -1.7, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "068760", | |
| "corpName": "셀트리온제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 5364, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 2.4, | |
| "opMargin": 11.3, | |
| "debtRatio": 89.2, | |
| "revCagr": null, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "214450", | |
| "corpName": "파마리서치", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 5363, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 7.0, | |
| "opMargin": 39.2, | |
| "debtRatio": 48.2, | |
| "revCagr": -17.6, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "145020", | |
| "corpName": "휴젤", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 4251, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 4.0, | |
| "opMargin": 40.8, | |
| "debtRatio": 9.6, | |
| "revCagr": 12.7, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "237690", | |
| "corpName": "에스티팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 3317, | |
| "confidence": 0.886, | |
| "source": "docs", | |
| "roe": 96.5, | |
| "opMargin": 17.2, | |
| "debtRatio": 39.0, | |
| "revCagr": -38.3, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "064550", | |
| "corpName": "바이오니아", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 3301, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -1.3, | |
| "opMargin": -0.6, | |
| "debtRatio": 69.1, | |
| "revCagr": 13.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "033270", | |
| "corpName": "유나이티드", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2888, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "007570", | |
| "corpName": "일양약품", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2724, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 6.6, | |
| "opMargin": -11.3, | |
| "debtRatio": 80.8, | |
| "revCagr": -8.6, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "214390", | |
| "corpName": "경보제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2641, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "234080", | |
| "corpName": "JW생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2578, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 3.1, | |
| "opMargin": 14.7, | |
| "debtRatio": 43.3, | |
| "revCagr": 7.5, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "019170", | |
| "corpName": "신풍제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2347, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 0.1, | |
| "opMargin": -0.7, | |
| "debtRatio": 27.2, | |
| "revCagr": -35.2, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "196170", | |
| "corpName": "알테오젠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2159, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 13.9, | |
| "opMargin": 54.9, | |
| "debtRatio": 42.2, | |
| "revCagr": 19.0, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "054670", | |
| "corpName": "대한뉴팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2024, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "003000", | |
| "corpName": "부광약품", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2007, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 0.3, | |
| "opMargin": 2.3, | |
| "debtRatio": 40.7, | |
| "revCagr": -27.6, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "004310", | |
| "corpName": "현대약품", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1918, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "053030", | |
| "corpName": "바이넥스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1685, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -5.4, | |
| "opMargin": -25.4, | |
| "debtRatio": 75.8, | |
| "revCagr": -3.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "144510", | |
| "corpName": "지씨셀", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1655, | |
| "confidence": 0.943, | |
| "source": "docs", | |
| "roe": -1.6, | |
| "opMargin": -13.7, | |
| "debtRatio": 71.1, | |
| "revCagr": -7.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "206650", | |
| "corpName": "유바이오로직스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1492, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -2.8, | |
| "opMargin": -0.7, | |
| "debtRatio": 39.0, | |
| "revCagr": 32.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "102460", | |
| "corpName": "이연제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1459, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -5.1, | |
| "opMargin": -18.5, | |
| "debtRatio": 116.8, | |
| "revCagr": -1.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "067080", | |
| "corpName": "대화제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1431, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -0.3, | |
| "opMargin": 1.2, | |
| "debtRatio": 161.4, | |
| "revCagr": 1.9, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "141080", | |
| "corpName": "리가켐바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1416, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -7.2, | |
| "opMargin": -104.3, | |
| "debtRatio": 30.4, | |
| "revCagr": 1.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "049180", | |
| "corpName": "셀루메드", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1402, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": -7.2, | |
| "opMargin": -6.7, | |
| "debtRatio": 186.9, | |
| "revCagr": 6.0, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "377740", | |
| "corpName": "바이오노트", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1183, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 2.7, | |
| "opMargin": 19.5, | |
| "debtRatio": 4.4, | |
| "revCagr": 14.4, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "005690", | |
| "corpName": "파미셀", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1141, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "058820", | |
| "corpName": "CMG제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1052, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 0.1, | |
| "opMargin": -11.5, | |
| "debtRatio": 58.3, | |
| "revCagr": -35.2, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "039200", | |
| "corpName": "오스코텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 998, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -2.8, | |
| "opMargin": -273.8, | |
| "debtRatio": 21.8, | |
| "revCagr": -9.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "028300", | |
| "corpName": "HLB", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 842, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -8.3, | |
| "opMargin": -124.1, | |
| "debtRatio": 87.4, | |
| "revCagr": -1.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "067290", | |
| "corpName": "JW신약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 810, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 45.2, | |
| "opMargin": 37.9, | |
| "debtRatio": 65.1, | |
| "revCagr": -42.3, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "298380", | |
| "corpName": "에이비엘바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 793, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 101.3, | |
| "opMargin": -131.1, | |
| "debtRatio": 62.6, | |
| "revCagr": 15.3, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "200780", | |
| "corpName": "비씨월드제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 758, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 1.1, | |
| "opMargin": 9.1, | |
| "debtRatio": 139.4, | |
| "revCagr": -35.8, | |
| "profGrade": "보통", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "278650", | |
| "corpName": "HLB바이오스텝", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 741, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -2.0, | |
| "opMargin": -19.4, | |
| "debtRatio": 44.0, | |
| "revCagr": 7.2, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "003060", | |
| "corpName": "에이프로젠바이오로직스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 732, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 117.4, | |
| "opMargin": -63.0, | |
| "debtRatio": 111.5, | |
| "revCagr": -7.2, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "214370", | |
| "corpName": "케어젠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 728, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": 5.5, | |
| "opMargin": 45.0, | |
| "debtRatio": 14.4, | |
| "revCagr": -2.7, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "183490", | |
| "corpName": "엔지켐생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 678, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": -1.3, | |
| "opMargin": -21.8, | |
| "debtRatio": 7.4, | |
| "revCagr": -5.1, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "223250", | |
| "corpName": "드림씨아이에스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 666, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -0.3, | |
| "opMargin": 3.1, | |
| "debtRatio": 84.8, | |
| "revCagr": -28.6, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "003120", | |
| "corpName": "일성아이에스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 643, | |
| "confidence": 0.5, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "309710", | |
| "corpName": "아이티켐", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 620, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 51.8, | |
| "opMargin": -1.2, | |
| "debtRatio": 144.7, | |
| "revCagr": null, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "086890", | |
| "corpName": "이수앱지스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 567, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "476060", | |
| "corpName": "온코닉테라퓨틱스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 534, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "049960", | |
| "corpName": "쎌바이오텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 531, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 4.0, | |
| "opMargin": 21.8, | |
| "debtRatio": 7.7, | |
| "revCagr": 5.5, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "041960", | |
| "corpName": "코미팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 525, | |
| "confidence": 0.7, | |
| "source": "docs", | |
| "roe": 0.9, | |
| "opMargin": 2.5, | |
| "debtRatio": 83.3, | |
| "revCagr": 15.1, | |
| "profGrade": "저수익", | |
| "debtGrade": "고위험", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "018680", | |
| "corpName": "서울제약", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 521, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "299170", | |
| "corpName": "더블유에스아이", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 517, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -0.1, | |
| "opMargin": -1.4, | |
| "debtRatio": 39.1, | |
| "revCagr": 14.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "072020", | |
| "corpName": "중앙백신", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 491, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 1.9, | |
| "opMargin": 18.5, | |
| "debtRatio": 19.4, | |
| "revCagr": 3.4, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "383930", | |
| "corpName": "디티앤씨알오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 477, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "0009K0", | |
| "corpName": "에임드바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 473, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -1.0, | |
| "opMargin": -46.6, | |
| "debtRatio": 4.1, | |
| "revCagr": 7338.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "067630", | |
| "corpName": "HLB생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 458, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -2.7, | |
| "opMargin": -42.5, | |
| "debtRatio": 65.0, | |
| "revCagr": -21.3, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "187420", | |
| "corpName": "HLB제넥스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 434, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -6.0, | |
| "opMargin": 8.6, | |
| "debtRatio": 154.7, | |
| "revCagr": -24.4, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "086040", | |
| "corpName": "바이오톡스텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 413, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -7.1, | |
| "opMargin": -15.4, | |
| "debtRatio": 344.7, | |
| "revCagr": 14.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "176750", | |
| "corpName": "듀켐바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 386, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 1.7, | |
| "opMargin": 12.9, | |
| "debtRatio": 54.1, | |
| "revCagr": -2.2, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "039860", | |
| "corpName": "나노엔텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 381, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 1.6, | |
| "opMargin": 1.4, | |
| "debtRatio": 9.4, | |
| "revCagr": -26.9, | |
| "profGrade": "저수익", | |
| "debtGrade": "안전", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "215380", | |
| "corpName": "우정바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 376, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "307280", | |
| "corpName": "원바이오젠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 352, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 4.4, | |
| "opMargin": 22.8, | |
| "debtRatio": 18.3, | |
| "revCagr": 10.1, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "138610", | |
| "corpName": "나이벡", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 327, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "217950", | |
| "corpName": "파마리서치바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 311, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "0120G0", | |
| "corpName": "삼양바이오팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 286, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "464280", | |
| "corpName": "티디에스팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 276, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "083790", | |
| "corpName": "CG인바이츠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 274, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -5.2, | |
| "opMargin": -142.3, | |
| "debtRatio": 92.2, | |
| "revCagr": -11.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "246710", | |
| "corpName": "티앤알바이오팹", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 270, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": -184.3, | |
| "opMargin": -27.5, | |
| "debtRatio": 328.1, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "314130", | |
| "corpName": "지놈앤컴퍼니", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 246, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -6.0, | |
| "opMargin": -105.4, | |
| "debtRatio": 52.6, | |
| "revCagr": 9.1, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "298060", | |
| "corpName": "에스씨엠생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 238, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -5.4, | |
| "opMargin": -9.7, | |
| "debtRatio": 48.9, | |
| "revCagr": -36.1, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "011000", | |
| "corpName": "진원생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 230, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -4.7, | |
| "opMargin": -90.8, | |
| "debtRatio": 156.6, | |
| "revCagr": -32.3, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "153710", | |
| "corpName": "옵티팜", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 223, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "007390", | |
| "corpName": "네이처셀", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 207, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": -1.8, | |
| "opMargin": -32.6, | |
| "debtRatio": 37.5, | |
| "revCagr": 1.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "166480", | |
| "corpName": "코아스템켐온", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 202, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -14.4, | |
| "opMargin": -137.7, | |
| "debtRatio": 119.3, | |
| "revCagr": -12.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "042520", | |
| "corpName": "한스바이오메드", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 199, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": 5.1, | |
| "opMargin": 12.9, | |
| "debtRatio": 100.0, | |
| "revCagr": 20.2, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "127120", | |
| "corpName": "제이에스링크", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 193, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -4.2, | |
| "opMargin": -203.4, | |
| "debtRatio": 60.4, | |
| "revCagr": -52.1, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "251120", | |
| "corpName": "바이오에프디엔씨", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 192, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "239610", | |
| "corpName": "에이치엘사이언스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 167, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -2.3, | |
| "opMargin": -105.2, | |
| "debtRatio": 2.8, | |
| "revCagr": -56.3, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "216400", | |
| "corpName": "인바이츠바이오코아", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 166, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -312.7, | |
| "opMargin": 1.3, | |
| "debtRatio": 3018.1, | |
| "revCagr": null, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "086820", | |
| "corpName": "바이오솔루션", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 152, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -4.9, | |
| "opMargin": -34.5, | |
| "debtRatio": 58.2, | |
| "revCagr": 8.4, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "046210", | |
| "corpName": "HLB파나진", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 150, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -1.4, | |
| "opMargin": -23.9, | |
| "debtRatio": 11.5, | |
| "revCagr": -51.3, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "222110", | |
| "corpName": "팬젠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 134, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "394800", | |
| "corpName": "쓰리빌리언", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 117, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -6.5, | |
| "opMargin": -49.4, | |
| "debtRatio": 25.9, | |
| "revCagr": -71.3, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "493280", | |
| "corpName": "아이엠바이오로직스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 116, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "142760", | |
| "corpName": "모아라이프플러스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 112, | |
| "confidence": 0.68, | |
| "source": "docs", | |
| "roe": -3.5, | |
| "opMargin": -58.2, | |
| "debtRatio": 35.6, | |
| "revCagr": -57.3, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "389030", | |
| "corpName": "지니너스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 105, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -7.4, | |
| "opMargin": -85.8, | |
| "debtRatio": 109.7, | |
| "revCagr": -30.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "263050", | |
| "corpName": "유틸렉스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 103, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -21.0, | |
| "opMargin": -206.7, | |
| "debtRatio": 155.5, | |
| "revCagr": 111.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "187660", | |
| "corpName": "페니트리움바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 93, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -14.8, | |
| "opMargin": -606.6, | |
| "debtRatio": 121.0, | |
| "revCagr": -9.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "334970", | |
| "corpName": "프레스티지바이오로직스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 89, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "299660", | |
| "corpName": "셀리드", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 88, | |
| "confidence": 0.943, | |
| "source": "docs", | |
| "roe": -8.9, | |
| "opMargin": -768.2, | |
| "debtRatio": 67.8, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "002630", | |
| "corpName": "오리엔트바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 86, | |
| "confidence": 0.92, | |
| "source": "docs", | |
| "roe": -32.2, | |
| "opMargin": 3.6, | |
| "debtRatio": 47.3, | |
| "revCagr": 202.2, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "245620", | |
| "corpName": "EDGC", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 79, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 103.6, | |
| "opMargin": -81.4, | |
| "debtRatio": 196.4, | |
| "revCagr": -59.6, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "229000", | |
| "corpName": "젠큐릭스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 75, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": -32.0, | |
| "opMargin": -219.9, | |
| "debtRatio": 172.3, | |
| "revCagr": 5.8, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "065660", | |
| "corpName": "안트로젠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 75, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "310210", | |
| "corpName": "보로노이", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 75, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -24.0, | |
| "opMargin": null, | |
| "debtRatio": 72.8, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "476830", | |
| "corpName": "알지노믹스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 71, | |
| "confidence": 0.943, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "323990", | |
| "corpName": "박셀바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 71, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -3.2, | |
| "opMargin": -730.9, | |
| "debtRatio": 7.3, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "115180", | |
| "corpName": "큐리언트", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 70, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -28.3, | |
| "opMargin": -394.8, | |
| "debtRatio": 66.7, | |
| "revCagr": -4.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "191420", | |
| "corpName": "테고사이언스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 59, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -4.1, | |
| "opMargin": -155.8, | |
| "debtRatio": 55.3, | |
| "revCagr": -46.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "358570", | |
| "corpName": "지아이이노베이션", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 58, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "331920", | |
| "corpName": "셀레믹스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 58, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": -34.5, | |
| "opMargin": -154.4, | |
| "debtRatio": 30.6, | |
| "revCagr": -48.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "048530", | |
| "corpName": "인트론바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 57, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -2.2, | |
| "opMargin": -113.3, | |
| "debtRatio": 7.9, | |
| "revCagr": -35.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "087010", | |
| "corpName": "펩트론", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 56, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "461030", | |
| "corpName": "아이엠비디엑스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 53, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "456070", | |
| "corpName": "이엔셀", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 53, | |
| "confidence": 0.943, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "196300", | |
| "corpName": "HLB펩", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 50, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "174900", | |
| "corpName": "앱클론", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 47, | |
| "confidence": 0.933, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "095700", | |
| "corpName": "제넥신", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 46, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -4.0, | |
| "opMargin": -609.9, | |
| "debtRatio": 26.8, | |
| "revCagr": 103.2, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "347850", | |
| "corpName": "디앤디파마텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 43, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -13.6, | |
| "opMargin": -8636.7, | |
| "debtRatio": 25.1, | |
| "revCagr": -76.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "464490", | |
| "corpName": "쿼드메디슨", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 42, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -17.1, | |
| "opMargin": -1612.5, | |
| "debtRatio": 73.3, | |
| "revCagr": -64.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "246250", | |
| "corpName": "에스엘에스바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 40, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "235980", | |
| "corpName": "메드팩토", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 39, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": -8.8, | |
| "opMargin": -316.6, | |
| "debtRatio": 6.5, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "293780", | |
| "corpName": "압타바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 37, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -15.8, | |
| "opMargin": -636.6, | |
| "debtRatio": 31.4, | |
| "revCagr": 385.1, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "217730", | |
| "corpName": "강스템바이오텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 36, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -7.3, | |
| "opMargin": -567.6, | |
| "debtRatio": 19.6, | |
| "revCagr": -33.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "185490", | |
| "corpName": "아이진", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 36, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -6.6, | |
| "opMargin": -277.7, | |
| "debtRatio": 27.1, | |
| "revCagr": -25.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "338840", | |
| "corpName": "와이바이오로직스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 29, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "304840", | |
| "corpName": "피플바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 29, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": -230.5, | |
| "debtRatio": 59.4, | |
| "revCagr": -15.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "084990", | |
| "corpName": "헬릭스미스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 26, | |
| "confidence": 0.943, | |
| "source": "docs", | |
| "roe": -1.0, | |
| "opMargin": -395.9, | |
| "debtRatio": 1.2, | |
| "revCagr": -20.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "348080", | |
| "corpName": "큐라티스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 25, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "476040", | |
| "corpName": "오가노이드사이언스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 24, | |
| "confidence": 0.92, | |
| "source": "docs", | |
| "roe": -22.0, | |
| "opMargin": -2955.2, | |
| "debtRatio": 58.4, | |
| "revCagr": -94.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "397030", | |
| "corpName": "에이프릴바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 22, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "373110", | |
| "corpName": "엑셀세라퓨틱스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 19, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": -44.8, | |
| "opMargin": -285.2, | |
| "debtRatio": 128.1, | |
| "revCagr": -3.1, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "308430", | |
| "corpName": "셀비온", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 19, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "284620", | |
| "corpName": "카이노스메드", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 12, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -38.3, | |
| "opMargin": -273.2, | |
| "debtRatio": 64.5, | |
| "revCagr": 73.8, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "203400", | |
| "corpName": "에이비온", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 9, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": -10.6, | |
| "opMargin": -1139.7, | |
| "debtRatio": 19.3, | |
| "revCagr": -4.0, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "200670", | |
| "corpName": "휴메딕스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 7, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 7.1, | |
| "opMargin": 13.9, | |
| "debtRatio": 52.1, | |
| "revCagr": null, | |
| "profGrade": "양호", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "378800", | |
| "corpName": "샤페론", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -16.7, | |
| "opMargin": -5607.8, | |
| "debtRatio": 16.5, | |
| "revCagr": -22.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "261780", | |
| "corpName": "차백신연구소", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 2, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "424870", | |
| "corpName": "이뮨온시아", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 1, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "475830", | |
| "corpName": "오름테라퓨틱", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -12.8, | |
| "opMargin": null, | |
| "debtRatio": 161.6, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "308080", | |
| "corpName": "바이젠셀", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": -4.5, | |
| "opMargin": null, | |
| "debtRatio": 16.2, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "288330", | |
| "corpName": "파라택시스코리아", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": 100.7, | |
| "opMargin": -642.7, | |
| "debtRatio": 53.3, | |
| "revCagr": 47.2, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "365270", | |
| "corpName": "큐라클", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "950210", | |
| "corpName": "프레스티지바이오파마", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -14.9, | |
| "opMargin": -9738.7, | |
| "debtRatio": 40.1, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "950160", | |
| "corpName": "코오롱티슈진", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "950220", | |
| "corpName": "네오이뮨텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.92, | |
| "source": "docs", | |
| "roe": -14.3, | |
| "opMargin": -1180.5, | |
| "debtRatio": 45.4, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "0007J0", | |
| "corpName": "인벤테라", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "140410", | |
| "corpName": "메지온", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -34.2, | |
| "opMargin": -226.4, | |
| "debtRatio": 537.8, | |
| "revCagr": -37.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "140610", | |
| "corpName": "엔솔바이오사이언스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "149300", | |
| "corpName": "아퓨어스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.85, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "215570", | |
| "corpName": "크로넥스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "222670", | |
| "corpName": "플럼라인생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "229500", | |
| "corpName": "노브메타파마", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "236340", | |
| "corpName": "메디젠휴먼케어", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "251280", | |
| "corpName": "안지오랩", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.886, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "266470", | |
| "corpName": "바이오인프라생명과학", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "291650", | |
| "corpName": "압타머사이언스", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -32.4, | |
| "opMargin": -7187.0, | |
| "debtRatio": 216.8, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "296160", | |
| "corpName": "프로젠", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.92, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "322970", | |
| "corpName": "무진메디", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "341170", | |
| "corpName": "퓨쳐메디신", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -318.0, | |
| "opMargin": null, | |
| "debtRatio": 238.2, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "372320", | |
| "corpName": "큐로셀", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -35.4, | |
| "opMargin": null, | |
| "debtRatio": 310.7, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "388870", | |
| "corpName": "파로스아이바이오", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": -18.6, | |
| "opMargin": null, | |
| "debtRatio": 135.6, | |
| "revCagr": null, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "446440", | |
| "corpName": "에피바이오텍", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "456190", | |
| "corpName": "큐라켐", | |
| "stage": "research", | |
| "role": "연구", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| } | |
| ] | |
| }, | |
| { | |
| "key": "api", | |
| "name": "원료의약품", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "nodes": [ | |
| { | |
| "stockCode": "000100", | |
| "corpName": "유한양행", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 21866, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 1.0, | |
| "opMargin": 1.7, | |
| "debtRatio": 40.0, | |
| "revCagr": 2.0, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "008930", | |
| "corpName": "한미사이언스", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 13570, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 4.2, | |
| "opMargin": 9.5, | |
| "debtRatio": 49.5, | |
| "revCagr": 4.6, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "003920", | |
| "corpName": "남양유업", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 9141, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 0.7, | |
| "opMargin": 0.2, | |
| "debtRatio": 19.3, | |
| "revCagr": -39.1, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "003520", | |
| "corpName": "영진약품", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 2543, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "023900", | |
| "corpName": "풍국주정", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 1635, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 1.7, | |
| "opMargin": 7.9, | |
| "debtRatio": 15.8, | |
| "revCagr": -4.7, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "063160", | |
| "corpName": "종근당바이오", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 1601, | |
| "confidence": 0.95, | |
| "source": "product", | |
| "roe": -4.4, | |
| "opMargin": -8.6, | |
| "debtRatio": 130.3, | |
| "revCagr": -45.4, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "004650", | |
| "corpName": "창해에탄올", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 1223, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 2.3, | |
| "opMargin": 15.0, | |
| "debtRatio": 36.6, | |
| "revCagr": -37.6, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "216080", | |
| "corpName": "제테마", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 769, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -3.3, | |
| "opMargin": -4.2, | |
| "debtRatio": 195.7, | |
| "revCagr": 0.0, | |
| "profGrade": "적자", | |
| "debtGrade": "고위험", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "106190", | |
| "corpName": "하이텍팜", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 702, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "034940", | |
| "corpName": "조아제약", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 593, | |
| "confidence": 0.3, | |
| "source": "docs", | |
| "roe": -0.6, | |
| "opMargin": -7.6, | |
| "debtRatio": 191.6, | |
| "revCagr": -3.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "041910", | |
| "corpName": "폴라리스AI파마", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 555, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 1.0, | |
| "opMargin": 8.3, | |
| "debtRatio": 10.4, | |
| "revCagr": 36.6, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "018620", | |
| "corpName": "우진비앤지", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 548, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -0.2, | |
| "opMargin": 4.9, | |
| "debtRatio": 68.2, | |
| "revCagr": -1.8, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "432980", | |
| "corpName": "엠에프씨", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 208, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "128940", | |
| "corpName": "한미약품", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 129, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 3.5, | |
| "opMargin": 13.7, | |
| "debtRatio": 50.5, | |
| "revCagr": 2.5, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "066830", | |
| "corpName": "제노텍", | |
| "stage": "api", | |
| "role": "제조", | |
| "stream": "upstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| } | |
| ] | |
| }, | |
| { | |
| "key": "formulation", | |
| "name": "완제의약품", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "nodes": [ | |
| { | |
| "stockCode": "003090", | |
| "corpName": "대웅", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 20684, | |
| "confidence": 0.68, | |
| "source": "docs", | |
| "roe": 80.2, | |
| "opMargin": 9.7, | |
| "debtRatio": 83.9, | |
| "revCagr": 4.2, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "006280", | |
| "corpName": "녹십자", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 19913, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 98.4, | |
| "opMargin": 2.7, | |
| "debtRatio": 112.1, | |
| "revCagr": -35.5, | |
| "profGrade": "우수", | |
| "debtGrade": "고위험", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "185750", | |
| "corpName": "종근당", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 16924, | |
| "confidence": 0.7, | |
| "source": "docs", | |
| "roe": 1.2, | |
| "opMargin": 3.1, | |
| "debtRatio": 78.1, | |
| "revCagr": -35.5, | |
| "profGrade": "저수익", | |
| "debtGrade": "안전", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "195940", | |
| "corpName": "HK이노엔", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 10632, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 0.7, | |
| "opMargin": 8.8, | |
| "debtRatio": 57.3, | |
| "revCagr": 33.5, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "082850", | |
| "corpName": "우리바이오", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 10440, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 0.2, | |
| "opMargin": -1.6, | |
| "debtRatio": 226.5, | |
| "revCagr": -40.3, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "001630", | |
| "corpName": "종근당홀딩스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 9590, | |
| "confidence": 0.68, | |
| "source": "docs", | |
| "roe": 1.9, | |
| "opMargin": 8.0, | |
| "debtRatio": 81.8, | |
| "revCagr": -35.1, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "243070", | |
| "corpName": "휴온스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 6208, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 0.1, | |
| "opMargin": -0.5, | |
| "debtRatio": 62.1, | |
| "revCagr": 0.3, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "003220", | |
| "corpName": "대원제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 6054, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": 0.7, | |
| "opMargin": 2.8, | |
| "debtRatio": 119.9, | |
| "revCagr": -33.1, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "200130", | |
| "corpName": "콜마비앤에이치", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 5749, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 5.9, | |
| "opMargin": 7.5, | |
| "debtRatio": 57.3, | |
| "revCagr": -4.4, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "483650", | |
| "corpName": "달바글로벌", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 5197, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 15.7, | |
| "opMargin": 26.3, | |
| "debtRatio": 28.7, | |
| "revCagr": 52.5, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "194700", | |
| "corpName": "노바렉스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 4043, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 5.1, | |
| "opMargin": 9.7, | |
| "debtRatio": 41.2, | |
| "revCagr": 25.1, | |
| "profGrade": "보통", | |
| "debtGrade": "관찰", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "001540", | |
| "corpName": "안국약품", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 3069, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 7.3, | |
| "opMargin": 16.2, | |
| "debtRatio": 91.0, | |
| "revCagr": 21.4, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "222040", | |
| "corpName": "코스맥스엔비티", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2875, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 15.0, | |
| "opMargin": 11.0, | |
| "debtRatio": 399.1, | |
| "revCagr": 5.1, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "317450", | |
| "corpName": "명인제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2873, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": 2.9, | |
| "opMargin": 34.8, | |
| "debtRatio": 9.6, | |
| "revCagr": -0.8, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "357230", | |
| "corpName": "에이치피오", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2582, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 1.6, | |
| "opMargin": 5.2, | |
| "debtRatio": 38.3, | |
| "revCagr": 4.2, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "006620", | |
| "corpName": "동구바이오제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2427, | |
| "confidence": 0.76, | |
| "source": "docs", | |
| "roe": -0.4, | |
| "opMargin": 3.1, | |
| "debtRatio": 128.5, | |
| "revCagr": -35.4, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "293480", | |
| "corpName": "하나제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2395, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "000250", | |
| "corpName": "삼천당제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2318, | |
| "confidence": 0.5, | |
| "source": "docs", | |
| "roe": 1.8, | |
| "opMargin": 8.4, | |
| "debtRatio": 45.3, | |
| "revCagr": 10.9, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "023910", | |
| "corpName": "대한약품", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2086, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "047920", | |
| "corpName": "HLB제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2056, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": 0.5, | |
| "opMargin": 1.6, | |
| "debtRatio": 33.6, | |
| "revCagr": -68.1, | |
| "profGrade": "저수익", | |
| "debtGrade": "안전", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "260660", | |
| "corpName": "알리코제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 2012, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "011040", | |
| "corpName": "경동제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1963, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 2.1, | |
| "opMargin": 5.0, | |
| "debtRatio": 34.7, | |
| "revCagr": 7.0, | |
| "profGrade": "보통", | |
| "debtGrade": "관찰", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "017180", | |
| "corpName": "명문제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1952, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -1.1, | |
| "opMargin": 0.6, | |
| "debtRatio": 164.9, | |
| "revCagr": 3.3, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "004720", | |
| "corpName": "팜젠사이언스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1731, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -0.3, | |
| "opMargin": 4.8, | |
| "debtRatio": 36.8, | |
| "revCagr": 7.3, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "234690", | |
| "corpName": "녹십자웰빙", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1647, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": -2.8, | |
| "opMargin": 9.8, | |
| "debtRatio": 117.8, | |
| "revCagr": 21.9, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "260970", | |
| "corpName": "에스앤디", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1509, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "000220", | |
| "corpName": "유유제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1409, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": 2.4, | |
| "opMargin": 12.1, | |
| "debtRatio": 45.4, | |
| "revCagr": -36.3, | |
| "profGrade": "양호", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "314140", | |
| "corpName": "알피바이오", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1362, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "307750", | |
| "corpName": "국전약품", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1310, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -2.6, | |
| "opMargin": 7.7, | |
| "debtRatio": 75.0, | |
| "revCagr": 5.1, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "060590", | |
| "corpName": "씨티씨바이오", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1238, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 4.6, | |
| "opMargin": 13.4, | |
| "debtRatio": 92.4, | |
| "revCagr": -37.0, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "007370", | |
| "corpName": "진양제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1207, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "002800", | |
| "corpName": "신신제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1138, | |
| "confidence": 0.6, | |
| "source": "docs", | |
| "roe": 3.7, | |
| "opMargin": 10.5, | |
| "debtRatio": 84.0, | |
| "revCagr": 8.7, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "330350", | |
| "corpName": "위더스제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1064, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "131030", | |
| "corpName": "옵투스제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 872, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "012790", | |
| "corpName": "신일제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 806, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "009300", | |
| "corpName": "삼아제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 778, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 1.0, | |
| "opMargin": 11.8, | |
| "debtRatio": 9.8, | |
| "revCagr": -10.6, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "032300", | |
| "corpName": "한국파마", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 737, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "관찰", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "377220", | |
| "corpName": "프롬바이오", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 722, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -15.1, | |
| "opMargin": -17.1, | |
| "debtRatio": 170.6, | |
| "revCagr": -0.2, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "348150", | |
| "corpName": "고바이오랩", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 693, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -0.6, | |
| "opMargin": -13.9, | |
| "debtRatio": 93.2, | |
| "revCagr": -16.6, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "086220", | |
| "corpName": "광동헬스바이오", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 670, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "014570", | |
| "corpName": "고려제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 625, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "082800", | |
| "corpName": "비보존 제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 593, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -5.7, | |
| "opMargin": -21.4, | |
| "debtRatio": 74.7, | |
| "revCagr": -0.6, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "053950", | |
| "corpName": "경남제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 559, | |
| "confidence": 0.84, | |
| "source": "docs", | |
| "roe": -0.8, | |
| "opMargin": 2.3, | |
| "debtRatio": 40.4, | |
| "revCagr": -38.2, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "080720", | |
| "corpName": "한국유니온제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 364, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": 9.1, | |
| "opMargin": -26.5, | |
| "debtRatio": null, | |
| "revCagr": -28.5, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "214260", | |
| "corpName": "라파스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 310, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": -2.5, | |
| "opMargin": -7.6, | |
| "debtRatio": 142.1, | |
| "revCagr": -3.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "471820", | |
| "corpName": "셀로맥스사이언스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 222, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": 7.4, | |
| "debtRatio": 9.2, | |
| "revCagr": -27.1, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "074430", | |
| "corpName": "아미노로직스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 220, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 1.9, | |
| "opMargin": 11.7, | |
| "debtRatio": 53.4, | |
| "revCagr": 8.9, | |
| "profGrade": "양호", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "223310", | |
| "corpName": "사토시홀딩스", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 189, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 100.4, | |
| "opMargin": -23.0, | |
| "debtRatio": 792.0, | |
| "revCagr": 8.1, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "215600", | |
| "corpName": "신라젠", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 92, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -4.7, | |
| "opMargin": -198.1, | |
| "debtRatio": 6.2, | |
| "revCagr": 3.2, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "114450", | |
| "corpName": "그린생명과학", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 11, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "120240", | |
| "corpName": "대정화금", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "014950", | |
| "corpName": "삼익제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": 1.8, | |
| "opMargin": 6.0, | |
| "debtRatio": 23.9, | |
| "revCagr": null, | |
| "profGrade": "보통", | |
| "debtGrade": "안전", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "199730", | |
| "corpName": "바이오인프라", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "289170", | |
| "corpName": "바이오텐", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "311960", | |
| "corpName": "인터로이드", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": -6.1, | |
| "opMargin": -18.4, | |
| "debtRatio": 66.8, | |
| "revCagr": -13.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "354390", | |
| "corpName": "바스칸바이오제약", | |
| "stage": "formulation", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.8, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| } | |
| ] | |
| }, | |
| { | |
| "key": "device", | |
| "name": "의료기기", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "nodes": [ | |
| { | |
| "stockCode": "069620", | |
| "corpName": "대웅제약", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 15709, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": 98.5, | |
| "opMargin": 5.9, | |
| "debtRatio": 112.3, | |
| "revCagr": 2.6, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "000640", | |
| "corpName": "동아쏘시오홀딩스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 14298, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 81.8, | |
| "opMargin": 5.5, | |
| "debtRatio": 79.3, | |
| "revCagr": 11.2, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "096530", | |
| "corpName": "씨젠", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 4742, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 3.4, | |
| "opMargin": 18.2, | |
| "debtRatio": 22.7, | |
| "revCagr": 15.0, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "145720", | |
| "corpName": "덴티움", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 3465, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 2.9, | |
| "opMargin": 22.2, | |
| "debtRatio": 67.1, | |
| "revCagr": -43.4, | |
| "profGrade": "우수", | |
| "debtGrade": "관찰", | |
| "growthGrade": "역성장" | |
| }, | |
| { | |
| "stockCode": "214150", | |
| "corpName": "클래시스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 3368, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": 6.4, | |
| "opMargin": 42.7, | |
| "debtRatio": 51.1, | |
| "revCagr": 21.8, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "439580", | |
| "corpName": "블루엠텍", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1859, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 5.6, | |
| "opMargin": -1.7, | |
| "debtRatio": 138.6, | |
| "revCagr": -42.5, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "340570", | |
| "corpName": "티앤엘", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1642, | |
| "confidence": 0.5, | |
| "source": "docs", | |
| "roe": 8.0, | |
| "opMargin": 40.5, | |
| "debtRatio": 16.5, | |
| "revCagr": 14.5, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "303810", | |
| "corpName": "동국생명과학", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1303, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "142280", | |
| "corpName": "녹십자엠에스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1084, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 152.7, | |
| "opMargin": 1.2, | |
| "debtRatio": 95.6, | |
| "revCagr": -37.0, | |
| "profGrade": "우수", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "059210", | |
| "corpName": "메타바이오메드", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1030, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": 3.4, | |
| "opMargin": 19.9, | |
| "debtRatio": 48.4, | |
| "revCagr": 4.9, | |
| "profGrade": "양호", | |
| "debtGrade": "관찰", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "071200", | |
| "corpName": "인피니트헬스케어", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 1024, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": 6.5, | |
| "opMargin": 29.4, | |
| "debtRatio": 27.8, | |
| "revCagr": -29.6, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "099430", | |
| "corpName": "바이오플러스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 909, | |
| "confidence": 0.5, | |
| "source": "docs", | |
| "roe": 4.5, | |
| "opMargin": 21.3, | |
| "debtRatio": 49.5, | |
| "revCagr": 14.8, | |
| "profGrade": "우수", | |
| "debtGrade": "안전", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "084650", | |
| "corpName": "랩지노믹스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 882, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -3.2, | |
| "opMargin": -23.3, | |
| "debtRatio": 57.5, | |
| "revCagr": 6.9, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "290650", | |
| "corpName": "엘앤씨바이오", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 855, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 1.3, | |
| "opMargin": 19.8, | |
| "debtRatio": 119.1, | |
| "revCagr": 27.0, | |
| "profGrade": "양호", | |
| "debtGrade": "관찰", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "003080", | |
| "corpName": "SB성보", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 643, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 3.0, | |
| "opMargin": 15.9, | |
| "debtRatio": 43.8, | |
| "revCagr": 59.5, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "0010V0", | |
| "corpName": "제이피아이헬스케어", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 485, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": 2.5, | |
| "opMargin": 4.3, | |
| "debtRatio": 30.7, | |
| "revCagr": -17.6, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "056090", | |
| "corpName": "시지메드텍", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 472, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 0.6, | |
| "opMargin": 1.8, | |
| "debtRatio": 32.9, | |
| "revCagr": 17.5, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "450950", | |
| "corpName": "아스테라시스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 379, | |
| "confidence": 1.0, | |
| "source": "docs", | |
| "roe": -2.2, | |
| "opMargin": -23.9, | |
| "debtRatio": 18.2, | |
| "revCagr": -49.1, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "043710", | |
| "corpName": "서울리거", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 357, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -7.9, | |
| "opMargin": 3.9, | |
| "debtRatio": 575.0, | |
| "revCagr": 92.5, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "149980", | |
| "corpName": "하이로닉", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 321, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 1.6, | |
| "opMargin": 15.2, | |
| "debtRatio": 11.3, | |
| "revCagr": 19.3, | |
| "profGrade": "양호", | |
| "debtGrade": "안전", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "219750", | |
| "corpName": "한국비티비", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 320, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": -0.4, | |
| "opMargin": 4.5, | |
| "debtRatio": 71.7, | |
| "revCagr": 27.0, | |
| "profGrade": "저수익", | |
| "debtGrade": "관찰", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "205470", | |
| "corpName": "휴마시스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 301, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": 1.5, | |
| "opMargin": -18.2, | |
| "debtRatio": 38.5, | |
| "revCagr": 38.6, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "고성장" | |
| }, | |
| { | |
| "stockCode": "221800", | |
| "corpName": "유투바이오", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 256, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "335810", | |
| "corpName": "프리시젼바이오", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 199, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": 0.3, | |
| "opMargin": 0.2, | |
| "debtRatio": 46.7, | |
| "revCagr": 4.9, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "450330", | |
| "corpName": "하스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 166, | |
| "confidence": 0.5, | |
| "source": "docs", | |
| "roe": -2.1, | |
| "opMargin": -24.6, | |
| "debtRatio": 21.4, | |
| "revCagr": -54.7, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "389650", | |
| "corpName": "넥스트바이오메디컬", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 165, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "214610", | |
| "corpName": "롤링스톤", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 109, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": -170.4, | |
| "debtRatio": 104.3, | |
| "revCagr": 7.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "정체" | |
| }, | |
| { | |
| "stockCode": "387570", | |
| "corpName": "파인메딕스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 95, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -4.1, | |
| "opMargin": -33.7, | |
| "debtRatio": 33.8, | |
| "revCagr": -76.6, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "253840", | |
| "corpName": "수젠텍", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 94, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -6.0, | |
| "opMargin": -199.6, | |
| "debtRatio": 29.7, | |
| "revCagr": 16.5, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "성장" | |
| }, | |
| { | |
| "stockCode": "394420", | |
| "corpName": "리센스메디컬", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 88, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": 46.7, | |
| "revCagr": -88.4, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "462510", | |
| "corpName": "라메디텍", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 72, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "384470", | |
| "corpName": "코어라인소프트", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 43, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": -19.4, | |
| "opMargin": -238.8, | |
| "debtRatio": 208.5, | |
| "revCagr": -31.8, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "228760", | |
| "corpName": "지노믹트리", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 38, | |
| "confidence": 0.9, | |
| "source": "docs", | |
| "roe": -1.6, | |
| "opMargin": -793.9, | |
| "debtRatio": 2.0, | |
| "revCagr": -31.1, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "352770", | |
| "corpName": "셀레스트라", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 20, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": 1.3, | |
| "opMargin": -1052.6, | |
| "debtRatio": null, | |
| "revCagr": -77.6, | |
| "profGrade": "저수익", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "109820", | |
| "corpName": "진매트릭스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 11, | |
| "confidence": 0.8, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "950130", | |
| "corpName": "엑세스바이오", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": -1.4, | |
| "opMargin": -209.6, | |
| "debtRatio": 8.8, | |
| "revCagr": -76.0, | |
| "profGrade": "적자", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| }, | |
| { | |
| "stockCode": "233250", | |
| "corpName": "메디안디노스틱", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "253610", | |
| "corpName": "루트락", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.92, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "402420", | |
| "corpName": "켈스", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 1.0, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "447690", | |
| "corpName": "아이오바이오", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.867, | |
| "source": "docs", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| }, | |
| { | |
| "stockCode": "456570", | |
| "corpName": "아이엠지티", | |
| "stage": "device", | |
| "role": "제조", | |
| "stream": "midstream", | |
| "revenue": 0, | |
| "confidence": 0.7, | |
| "source": "product", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| } | |
| ] | |
| }, | |
| { | |
| "key": "distribution", | |
| "name": "유통", | |
| "role": "도매", | |
| "stream": "downstream", | |
| "nodes": [ | |
| { | |
| "stockCode": "118000", | |
| "corpName": "메타케어", | |
| "stage": "distribution", | |
| "role": "도매", | |
| "stream": "downstream", | |
| "revenue": 328, | |
| "confidence": 0.733, | |
| "source": "docs", | |
| "roe": 0.6, | |
| "opMargin": 5.7, | |
| "debtRatio": 55.1, | |
| "revCagr": -43.4, | |
| "profGrade": "보통", | |
| "debtGrade": "주의", | |
| "growthGrade": "급감" | |
| } | |
| ] | |
| } | |
| ], | |
| "unclassified": [ | |
| { | |
| "stockCode": "036480", | |
| "corpName": "대성미생물", | |
| "stage": "", | |
| "role": "", | |
| "stream": "", | |
| "revenue": 0, | |
| "confidence": 0.7, | |
| "source": "kindlist", | |
| "roe": null, | |
| "opMargin": null, | |
| "debtRatio": null, | |
| "revCagr": null, | |
| "profGrade": "", | |
| "debtGrade": "", | |
| "growthGrade": "" | |
| } | |
| ], | |
| "edges": [ | |
| { | |
| "from": "271980", | |
| "to": "003520", | |
| "type": "supplier", | |
| "amount": 3549.0, | |
| "ratio": null, | |
| "product": "CMZ(I)", | |
| "confidence": 0.9, | |
| "source": "docs_table" | |
| }, | |
| { | |
| "from": "120240", | |
| "to": "196300", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.9, | |
| "source": "docs_table" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "000100", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "140610", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "296160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "308430", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "424870", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "0009K0", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "358570", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "397030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "205470", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "064550", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "063160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "185750", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "001630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "170900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "000640", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "131030", | |
| "to": "000250", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000250", | |
| "to": "131030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000640", | |
| "to": "170900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000640", | |
| "to": "237690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000640", | |
| "to": "140410", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001540", | |
| "to": "174900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "063160", | |
| "to": "001630", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "001630", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "001630", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "185750", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "063160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "214390", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "023910", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "084990", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "128940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "140410", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "085660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "084650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "086040", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "065660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003000", | |
| "to": "065660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003000", | |
| "to": "185490", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003060", | |
| "to": "296160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "296160", | |
| "to": "003060", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "069620", | |
| "to": "003090", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003090", | |
| "to": "069620", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003090", | |
| "to": "314140", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "003090", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "003090", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "003520", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "003520", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "128940", | |
| "to": "003520", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003850", | |
| "to": "308080", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "063160", | |
| "to": "003850", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "003850", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "004720", | |
| "to": "950130", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "004720", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "004720", | |
| "to": "023910", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "006280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "144510", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "234690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "142280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "199730", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "005250", | |
| "to": "249420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "005250", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "144510", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "234690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "142280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "199730", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "206650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "249420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "115180", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "347850", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "314130", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "128940", | |
| "to": "008930", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "008930", | |
| "to": "128940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "008930", | |
| "to": "000640", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "008930", | |
| "to": "170900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "011040", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "000100", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "207940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "069620", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "185750", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "001630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "243070", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "017180", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "018620", | |
| "to": "006280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "067630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "187420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "278650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "046210", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "196300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "047920", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "034940", | |
| "to": "033270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "039860", | |
| "to": "302440", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "039860", | |
| "to": "033270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "039860", | |
| "to": "326030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "041910", | |
| "to": "048530", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "041910", | |
| "to": "464490", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "002630", | |
| "to": "041960", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "046210", | |
| "to": "229000", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "046210", | |
| "to": "028300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "046210", | |
| "to": "187420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "046210", | |
| "to": "196300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "047920", | |
| "to": "028300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "047920", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "047920", | |
| "to": "067080", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "048530", | |
| "to": "102460", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "296160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "196170", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053950", | |
| "to": "205470", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "054670", | |
| "to": "068270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "054670", | |
| "to": "023910", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "056090", | |
| "to": "003090", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "058820", | |
| "to": "261780", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "058820", | |
| "to": "085660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "060590", | |
| "to": "048530", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "063160", | |
| "to": "185750", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "063160", | |
| "to": "001630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "063160", | |
| "to": "214390", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "065660", | |
| "to": "003000", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067080", | |
| "to": "207940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067080", | |
| "to": "004310", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067080", | |
| "to": "128940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067290", | |
| "to": "234080", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "067630", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "028300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "187420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "278650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "046210", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "196300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "047920", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "068270", | |
| "to": "086820", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "068270", | |
| "to": "068760", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "068270", | |
| "to": "086040", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "068760", | |
| "to": "068270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "068760", | |
| "to": "086820", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "069620", | |
| "to": "314140", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "069620", | |
| "to": "003090", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "069620", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "069620", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "074430", | |
| "to": "358570", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "083790", | |
| "to": "216400", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "083790", | |
| "to": "243070", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "083790", | |
| "to": "222110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "084110", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "084110", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "140610", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "243070", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "222110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "200670", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "008930", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "128940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "200130", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "432980", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "069620", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "246710", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "086040", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "003000", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "102460", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084650", | |
| "to": "203400", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084650", | |
| "to": "402420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "084990", | |
| "to": "086820", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "085660", | |
| "to": "058820", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "085660", | |
| "to": "261780", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "085660", | |
| "to": "476040", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "068270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "068760", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "215380", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "183490", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "005690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086220", | |
| "to": "335810", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "303810", | |
| "to": "086450", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "303810", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "249420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "011040", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "006620", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "001540", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "004310", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086820", | |
| "to": "084990", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "338840", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "053030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "127120", | |
| "to": "290650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "128940", | |
| "to": "008930", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "128940", | |
| "to": "000640", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "128940", | |
| "to": "170900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "131030", | |
| "to": "000250", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "137310", | |
| "to": "377740", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "137310", | |
| "to": "206650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "137310", | |
| "to": "060590", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "137310", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "140410", | |
| "to": "237690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "140410", | |
| "to": "170900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "140410", | |
| "to": "000640", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "140610", | |
| "to": "200670", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "140610", | |
| "to": "000100", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "141080", | |
| "to": "354390", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "142280", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "142280", | |
| "to": "006280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "142280", | |
| "to": "005250", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "142280", | |
| "to": "144510", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "142280", | |
| "to": "234690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "142280", | |
| "to": "199730", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086220", | |
| "to": "142760", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "142760", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "194700", | |
| "to": "142760", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "142760", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "142760", | |
| "to": "296160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "144510", | |
| "to": "006280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "144510", | |
| "to": "005250", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "144510", | |
| "to": "234690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "144510", | |
| "to": "142280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "144510", | |
| "to": "199730", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "144510", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "145020", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "145020", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "145020", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "145020", | |
| "to": "260970", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "145020", | |
| "to": "246710", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "153710", | |
| "to": "340570", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "153710", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "170900", | |
| "to": "237690", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "170900", | |
| "to": "000640", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "237690", | |
| "to": "170900", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "170900", | |
| "to": "140410", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "206650", | |
| "to": "185490", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "001630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "063160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "214390", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "063160", | |
| "to": "185750", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "128940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "187420", | |
| "to": "086890", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "195940", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "194700", | |
| "to": "195940", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "200130", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "195940", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "314140", | |
| "to": "195940", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "195940", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "239610", | |
| "to": "195940", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "338840", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "341170", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "222110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "196300", | |
| "to": "028300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "084110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "243070", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "222110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "246710", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "008930", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "402420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "200130", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "128940", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "069620", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "086040", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "003090", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "249420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "102460", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "012790", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "085660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "206650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "205470", | |
| "to": "053950", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "206650", | |
| "to": "222670", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214370", | |
| "to": "042520", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "185750", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "001630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "063160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "017180", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214450", | |
| "to": "217950", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "216400", | |
| "to": "083790", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "217730", | |
| "to": "028300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "217950", | |
| "to": "214450", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "221800", | |
| "to": "003090", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "331920", | |
| "to": "221800", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "222110", | |
| "to": "084110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "222110", | |
| "to": "243070", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "222110", | |
| "to": "200670", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "223310", | |
| "to": "053950", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "099430", | |
| "to": "228760", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "234080", | |
| "to": "067290", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "234690", | |
| "to": "006280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "234690", | |
| "to": "005250", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "234690", | |
| "to": "142280", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "234690", | |
| "to": "144510", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "234690", | |
| "to": "199730", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "237690", | |
| "to": "000640", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "237690", | |
| "to": "170900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "084110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "222110", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "200670", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "140610", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "456570", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "251280", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "260660", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "261780", | |
| "to": "085660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "261780", | |
| "to": "058820", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "266470", | |
| "to": "199730", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "271980", | |
| "to": "476060", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "028300", | |
| "to": "278650", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "028300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "187420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "046210", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "067630", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "047920", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "196300", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "214260", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "389650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "284620", | |
| "to": "389650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "293480", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "003220", | |
| "to": "293480", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "439580", | |
| "to": "293780", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "314140", | |
| "to": "293780", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "293780", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "194700", | |
| "to": "293780", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "296160", | |
| "to": "000100", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "296160", | |
| "to": "424870", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "298060", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "302440", | |
| "to": "033270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "302440", | |
| "to": "039860", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "302440", | |
| "to": "326030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "303810", | |
| "to": "086450", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "378800", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "308080", | |
| "to": "003850", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "128940", | |
| "to": "310210", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "326030", | |
| "to": "302440", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "326030", | |
| "to": "033270", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "326030", | |
| "to": "039860", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "331920", | |
| "to": "461030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "334970", | |
| "to": "950210", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "338840", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "338840", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "348150", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "348150", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "354390", | |
| "to": "141080", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "357230", | |
| "to": "194700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "357230", | |
| "to": "236340", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "207940", | |
| "to": "358570", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "358570", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "358570", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "358570", | |
| "to": "338840", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "377220", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "194700", | |
| "to": "377220", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "137310", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "060590", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "206650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "214450", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "217950", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "378800", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "378800", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "067080", | |
| "to": "378800", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "308430", | |
| "to": "378800", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "054670", | |
| "to": "378800", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "215380", | |
| "to": "383930", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "237690", | |
| "to": "388870", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "120240", | |
| "to": "388870", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "207940", | |
| "to": "397030", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "053030", | |
| "to": "397030", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "246250", | |
| "to": "397030", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "424870", | |
| "to": "000100", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "424870", | |
| "to": "296160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "290650", | |
| "to": "461030", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "461030", | |
| "to": "331920", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "331920", | |
| "to": "461030", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "200130", | |
| "to": "471820", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "314140", | |
| "to": "471820", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "194700", | |
| "to": "471820", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "271980", | |
| "to": "476060", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "476060", | |
| "to": "271980", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "950130", | |
| "to": "004720", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "334970", | |
| "to": "950210", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "950210", | |
| "to": "334970", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "950220", | |
| "to": "095700", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.5, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "950220", | |
| "type": "supplier", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.7, | |
| "source": "docs" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "308430", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "095700", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "000100", | |
| "to": "0009K0", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "000640", | |
| "to": "309710", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "145020", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "140410", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "095700", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "128940", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "084990", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "483650", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "039200", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "207940", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "053030", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "000100", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "358570", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "096530", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "141080", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "196170", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "214450", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "084650", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "214150", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "476830", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "950160", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "001630", | |
| "to": "008930", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "002800", | |
| "to": "308430", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "003220", | |
| "to": "389650", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006280", | |
| "to": "206650", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "314130", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "377740", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "017180", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "307750", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "060590", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "462510", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "006620", | |
| "to": "290650", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "008930", | |
| "to": "170900", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "008930", | |
| "to": "000640", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "000100", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "207940", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "011040", | |
| "to": "007370", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "023900", | |
| "to": "003920", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "048530", | |
| "to": "102460", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "054670", | |
| "to": "207940", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "054670", | |
| "to": "068270", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "187420", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "067630", | |
| "to": "028300", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "069620", | |
| "to": "446440", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "069620", | |
| "to": "402420", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "083790", | |
| "to": "222110", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "086040", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "003090", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "003000", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "008930", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "456570", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "128940", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "432980", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "200130", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "069620", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "246710", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084110", | |
| "to": "102460", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084650", | |
| "to": "203400", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "084650", | |
| "to": "402420", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "005690", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "086040", | |
| "to": "183490", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "086450", | |
| "to": "0007J0", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "053030", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "358570", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "296160", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "095700", | |
| "to": "338840", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "144510", | |
| "to": "234690", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "174900", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "185750", | |
| "to": "456070", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "439580", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "341170", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "195940", | |
| "to": "338840", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "008930", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "003090", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "200130", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "086040", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "140610", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "402420", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "246710", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "069620", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "085660", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "249420", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "206650", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "102460", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "128940", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "200670", | |
| "to": "012790", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "205470", | |
| "to": "053950", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "214370", | |
| "to": "042520", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "214370", | |
| "to": "096530", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "214390", | |
| "to": "017180", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "214450", | |
| "to": "060590", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.9, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "219750", | |
| "to": "069620", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "219750", | |
| "to": "302440", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "219750", | |
| "to": "249420", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "223250", | |
| "to": "246710", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "229000", | |
| "to": "203400", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "229500", | |
| "to": "120240", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "237690", | |
| "to": "309710", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "950210", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "456570", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "243070", | |
| "to": "308430", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "251120", | |
| "to": "338840", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "389650", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "046210", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "322970", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "278650", | |
| "to": "196300", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "303810", | |
| "to": "0007J0", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "307750", | |
| "to": "006620", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "357230", | |
| "to": "194700", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "358570", | |
| "to": "338840", | |
| "type": "investor", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "373110", | |
| "to": "229000", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "377740", | |
| "to": "299660", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.6, | |
| "source": "network" | |
| }, | |
| { | |
| "from": "950220", | |
| "to": "950220", | |
| "type": "affiliate", | |
| "amount": null, | |
| "ratio": null, | |
| "product": "", | |
| "confidence": 0.9, | |
| "source": "network" | |
| } | |
| ] | |
| } |